News & Press
Lausanne, Switzerland, February 3rd, 2017
Biowatch, winner of multiple challenges since its birth at the ICC in 2014
Biowatch’s vein recognition technology won them € 25’000 in the Visa Everywhere Initiative, which was held for the first time in Europe. The pitch competition was kicked-off at the World Mobile Congress. Biowatch also qualified for the larger European competition which awards €50’000 and the opportunity to work with Visa.
Lausanne, Switzerland, February 3rd, 2017 - Biowatch SA won the 1st prize at the 2017 Swiss Fintech Convention held in Geneva on February 2nd, pitching its disruptive vein based biometric solution. The Swiss startup outlined several ongoing projects in the banking industry and the upcoming functional pre-products for Spring 2017.
Registration for the ICC'2017 is open now !!!
The Investor Summit is a global event connecting Swiss start-ups with over 200 top international investors in an effort to strengthen Switzerland’s international position as a global hub for innovation and entrepreneurship. 18 companies have been selected to present their business cases in pitches and exhibitions.
This year, 135 ventures applied to the competition and most of the entries were of extremely high quality.
On Tuesday, September 20th, after three weeks of hard work and networking, the ICC’2016 participants found out which teams the jury had selected among the winners of the challenge. The organizers of the ICC’2016 are proud to announce the following winning teams:
Recapp, an Idiap spin-off and sponsored by The Ark Foundation, is part of the top 100 Swiss Startups 2016. It's a big success for Dr. David Imseng, founder of Recapp.
An ICC'2016 participant, Dental Simulator, has been chosen to present its idea to a large audience at the TEDx Martigny Friday September 9, 2016.
Eyeware, young Valaisan start-up and winner of the ICC’2015, featured in RTS’ radio show “Néophiles”
Kenneth Funes, whose project “Eyeware” was amongst the winners of the ICC’2015, is currently founding the start-up Eyeware in Martigny (Valais). It develops gaze and interaction technologies based on his PhD work done in the Idiap Perception and Activity Understanding group. The EyewareAssit system allows interacting with a computer via the head and facial gestures, and is particularly aimed at people with paraplegia who are unable to use a standard keyboard or mouse.
Recapp IT and KeyLemon, two Idiap spin-offs, have contributed to the development of the new TV Box of Swisscom by allowing for the first time the voice recognition of Swiss-German dialects.
The Valais start-up Recapp, founded in March 2014, launched this spring, together with Idiap, two ambitious projects in the domain of voice recognition and data transcription.
BioWatch, a successful Idiap spin-off, highlighted in the magazine of the Federation of the Swiss Watch Industry FH
BioWatch, whose flagship product is a biometric identification system integrated into the buckle of a watchband that enables the secure authentication of a person by detecting the unique pattern of veins on the wrist, has captured the attention and the interest of the Swiss watch industry.
50 start-ups in Bilan magazine: Recapp, winner of the ICC’2013 and Idiap spin-off, counts amongst them
Each week, Bilan magazine proposes three inspiring start-ups in which to invest, based on its 2016 selection. Currently, the spotlight is on the young Valaisan start-up Recapp.
Anemomind, winner of the ICC’2014, launches a new application “Anemomind Connect” that allows mariners worldwide to better understand their sailing boat. The application is a 100% swiss-made.
Registration for the ICC'2016 is open now !!!
For its 2016 edition, the ICC can count on the support of a new media partner, Startupolic.
Biowatch and Embotech made it to the finals of the UBS Future of Finance Challenge. The global finals will take place in Zurich on 10 December.
Quinze start-up sélectionnées pour la zone EMEA du concours fintech «UBS Future of Finance Challenge» participent à la finale régionale à Zurich. La Romandie est représentée par Biowatch, CashSentinel et Nviso.